Arch Biopartners Inc.
ARCH.VTSXVHealthcare● Active
$0.48
$-0.01(-2.04%)
Market Cap$32607979
P/E Ratio—
52W High$1.95
52W Low$0.39
Arch Biopartners Inc.（ARCH.V）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ARCH.V · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | -78.05% | -6.50% | -52.14% | -3.86% |
| Operating Expenses | |||||
| R&D Expenses | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | -186.00% | -169.10% | -143.99% | -29.97% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | -184.73% | -167.69% | -145.95% | -30.10% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.06 | $-0.05 | $-0.02 | $-0.02 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B |
| EBITDA | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | -166.39% | -16.94% | -10.47% | -1.98% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CAD · B
深入了解Arch Biopartners Inc.
关于Arch Biopartners Inc.（ARCH.V）损益表
Arch Biopartners Inc.（ARCH.V）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ARCH.V实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.00B)（净利率—）。
常见问题
ARCH.V · 4 问Arch Biopartners Inc.（ARCH.V）2025财年营收为$0.00B，同比down100.0%。
ARCH.V revenueARCH.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08